# Bristol-Myers Squibb Company (BMY) — Q1-2013 Earnings Results

**Report date:** 2013-04-25 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q1-2013

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Misses on EPS, Stock Down 2.97%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.41 | N/A | -0.73% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Defensive

Management expressed caution regarding future performance without offering specific guidance. They emphasized a focus on their existing product lineup.

**Key quotes:**

> Management did not provide specific guidance for the upcoming quarters.

> The company is focusing on maintaining its current portfolio amid market challenges.

### Guidance Changes

No guidance data was available for this quarter.

### What It Means

Bristol Myers Squibb's earnings report indicates a slight miss on EPS, which contributed to a 2.97% drop in stock price. The lack of revenue data and forward guidance may have raised concerns among investors about the company's near-term performance. The defensive tone from management suggests they are navigating challenges without clear expectations for improvement.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q1-2013_